by ADRIAN MANZ | Jul 22, 2025 | The Doctor's Dose
Netflix Earnings Beat Expectations, But Stock Dips as Growth Questions Loom Netflix (NFLX) has long been the dominant force in streaming, consistently outpacing competitors in revenue, profit, and global reach. But even the leader isn’t immune to market...
by ADRIAN MANZ | Apr 22, 2025 | The Doctor's Dose
Earnings Spotlight: What Traders Should Watch April 22–25, 2025 The upcoming trading week is packed with earnings announcements from major market movers—Tesla, Intuitive Surgical, Equifax, Chipotle, and Alphabet—alongside critical macroeconomic data that could...
by ADRIAN MANZ | Mar 13, 2025 | The Doctor's Dose
Retaliatory Tariffs Impact on US Stock Market: What Traders Need to Know Understanding Retaliatory Tariffs and Their Market Influence The impact of retaliatory tariffs on the US stock market is a hot topic among traders and economists. As global trade tensions rise,...
by ADRIAN MANZ | Jan 30, 2025 | The Doctor's Dose
AAPL Earnings Report – Here’s What to Watch For As Apple prepares to release its latest earnings report after the bell today, traders and investors are zeroing in on one critical figure: Apple earnings report iPhone sales in China. With Apple’s stock...
by ADRIAN MANZ | Nov 6, 2024 | The Doctor's Dose
In the wake of Donald Trump’s recent victory, the markets are bracing for shifts traders need to anticipate. Trump’s policies and leadership style have historically impacted various market sectors, and his return will likely influence trading strategies across...
